Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
Overview of Ovarian Cancer - CancerConnect
Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment
The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review - ScienceDirect
Cancers | Free Full-Text | Future Screening Prospects for Ovarian Cancer
CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
Associate Professor Susan Jordan - School of Public Health - University of Queensland
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium | British Journal of Cancer
Exploiting epigenetic dependencies in ovarian cancer therapy - Coughlan - 2021 - International Journal of Cancer - Wiley Online Library
Frontiers | Association Between Benign Ovarian Tumors and Ovarian Cancer Risk: A Meta-Analysis of Ten Epidemiological Studies
Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis
Epidemiology of epithelial ovarian cancer - ScienceDirect
Frontiers | Stress Hormones: Emerging Targets in Gynecological Cancers
RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges - Ye - WIREs RNA - Wiley Online Library
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer
Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark‐2 study - Cabasag - 2023 - International Journal of Cancer - Wiley Online Library
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
